Linnaeus Therapeutics, Inc. announced that on June 28, 2022 the U.S. Patent and Trademark Office (USPTO) issued U.S. patent 11,369,618 ('618...
Read more
Axial Therapeutics announced that A. Stewart Campbell, Ph.D., will participate in a panel entitled “The Next Wave of Targeted...
Read more
Linnaeus Therapeutics announced the presentation of clinical biomarker data from its study of LNS8801 as a monotherapy and in...
Read more
Dr. Jane Goodall and Vivodyne announced that they have delivered a letter to Congress urging its inclusion of the...
Read more
Flash Memory Summit (FMS) is pleased to announce its 2022 Best of Show Award winners. This year's awards recognize...
Read more
Jim Demetriades speaks with MoochFM host Anthony Scaramucci to discuss investing in science and its ability to change the...
Read more
Seed Health and Axial Therapeutics announced a joint development program targeting the microbiome-gut-brain axis for mental health, with the potential...
Read more
Behavioral Signals, a Los Angeles-based software company and provider in Conversational AI technology, announces its partnership with ddCom Systems,...
Read more
MemVerge Memory Machine™ has achieved Red Hat OpenShift Operator and container certifications. This is an important step in enabling...
Read more
Provivi will participate in the World Agri-Tech South America Summit as a Gold Partner, taking place virtually and in...
Read more